These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 8839260)
1. Glucose transporter 2 expression: prevention of streptozotocin-induced reduction in beta-cells with 5-thio-D-glucose. Wang Z; Gleichmann H Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():83-97. PubMed ID: 8839260 [TBL] [Abstract][Full Text] [Related]
2. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro. Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569 [TBL] [Abstract][Full Text] [Related]
3. Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin. Hosokawa M; Dolci W; Thorens B Biochem Biophys Res Commun; 2001 Dec; 289(5):1114-7. PubMed ID: 11741307 [TBL] [Abstract][Full Text] [Related]
4. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy. Reddy S; Young M; Poole CA; Ross JM Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017 [TBL] [Abstract][Full Text] [Related]
5. KATP channel-deficient pancreatic beta-cells are streptozotocin resistant because of lower GLUT2 activity. Xu J; Zhang L; Chou A; Allaby T; Bélanger G; Radziuk J; Jasmin BJ; Miki T; Seino S; Renaud JM Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E326-35. PubMed ID: 18042662 [TBL] [Abstract][Full Text] [Related]
6. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Wang Z; Gleichmann H Diabetes; 1998 Jan; 47(1):50-6. PubMed ID: 9421374 [TBL] [Abstract][Full Text] [Related]
7. Molecular target structures in alloxan-induced diabetes in mice. im Walde SS; Dohle C; Schott-Ohly P; Gleichmann H Life Sci; 2002 Aug; 71(14):1681-94. PubMed ID: 12137914 [TBL] [Abstract][Full Text] [Related]
8. Importance of the GLUT2 glucose transporter for pancreatic beta cell toxicity of alloxan. Elsner M; Tiedge M; Guldbakke B; Munday R; Lenzen S Diabetologia; 2002 Nov; 45(11):1542-9. PubMed ID: 12436338 [TBL] [Abstract][Full Text] [Related]
9. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo. Sternesjö J; Welsh N; Sandler S Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135 [TBL] [Abstract][Full Text] [Related]
10. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus. Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170 [TBL] [Abstract][Full Text] [Related]
11. Destruction of pancreatic beta cells in rats by complete Freund's adjuvant combined with non-diabetogenic doses of streptozotocin. Kohnert KD; Odselius R; Fält K; Ziegler B; Ziegler M; Falkmer S Diabetes Res; 1987 May; 5(1):1-11. PubMed ID: 2957141 [TBL] [Abstract][Full Text] [Related]
12. Intervention of D-glucose ameliorates the toxicity of streptozotocin in accessory sex organs of rat. Vikram A; Tripathi DN; Ramarao P; Jena GB Toxicol Appl Pharmacol; 2008 Jan; 226(1):84-93. PubMed ID: 17950394 [TBL] [Abstract][Full Text] [Related]
13. Mediation of beta-endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats. Liu IM; Chen WC; Cheng JT J Pharmacol Exp Ther; 2003 Dec; 307(3):1196-204. PubMed ID: 12975496 [TBL] [Abstract][Full Text] [Related]
14. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice. Herold KC; Baumann E; Vezys V; Buckingham F J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296 [TBL] [Abstract][Full Text] [Related]
15. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice. Jetton TL; Liang Y; Cincotta AH Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060 [TBL] [Abstract][Full Text] [Related]
16. Insulin and GLUT2 glucose transporter immunoreactivity in B-cells of whole pancreas isografts and allografts in the streptozotocin-diabetic rat. Jörns A; Klempnauer J Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():103-6. PubMed ID: 8839264 [TBL] [Abstract][Full Text] [Related]
18. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. O'Brien BA; Harmon BV; Cameron DP; Allan DJ J Pathol; 1996 Feb; 178(2):176-81. PubMed ID: 8683386 [TBL] [Abstract][Full Text] [Related]
19. Did the gradual loss of GLUT2 cause a shift to diabetic disorders in the New Zealand obese mouse (NZO/Hl)? Chankiewitz E; Peschke D; Herberg L; Bazwinsky I; Mühlbauer E; Brömme HJ; Peschke E Exp Clin Endocrinol Diabetes; 2006 May; 114(5):262-9. PubMed ID: 16804801 [TBL] [Abstract][Full Text] [Related]
20. High glucose potentiates cytokine- and streptozotocin-induced apoptosis of rat islet cells: effect on apoptosis-related genes. Mellado-Gil JM; Aguilar-Diosdado M J Endocrinol; 2004 Oct; 183(1):155-62. PubMed ID: 15525583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]